{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:41:07Z","timestamp":1781012467675,"version":"3.54.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS104423"],"award-info":[{"award-number":["R01 NS104423"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS115002"],"award-info":[{"award-number":["R01 NS115002"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R03 NS114871"],"award-info":[{"award-number":["R03 NS114871"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R13 NS117005"],"award-info":[{"award-number":["R13 NS117005"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS104326"],"award-info":[{"award-number":["U01 NS104326"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008447","name":"International Essential Tremor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000882","name":"Brain Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00902","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:26:40Z","timestamp":1598416000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Collaborative Efforts for Spinocerebellar Ataxia Research in the United States: CRC-SCA and READISCA"],"prefix":"10.3389","volume":"11","author":[{"given":"Chih-Chun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Han","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/acn3.374","article-title":"Degenerative ataxias: challenges in clinical research","volume":"4","author":"Subramony","year":"2017","journal-title":"Ann Clin Transl Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1212\/WNL.58.5.702","article-title":"Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis","volume":"58","author":"van de Warrenburg","year":"2002","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr","year":"1993","journal-title":"Nat Genet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15788.1","article-title":"Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view","volume":"7","author":"Coarelli","year":"2018","journal-title":"F1000Research."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat Rev Dis Prim."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome","volume":"145","author":"Trouillas","year":"1997","journal-title":"J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","article-title":"Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale","volume":"64","author":"Subramony","year":"2005","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: Development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1212\/WNL.0b013e31822e7ca0","article-title":"The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study","volume":"77","author":"Jacobi","year":"2011","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S1474-4422(13)70104-2","article-title":"Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data","volume":"12","author":"Jacobi","year":"2013","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1750-1172-8-177","article-title":"Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; A prospective observational study","volume":"8","author":"Ashizawa","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","article-title":"Inventory of non-ataxia signs (INAS): validation of a new clinical assessment instrument","volume":"12","author":"Jacobi","year":"2013","journal-title":"Cerebellum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/brain\/awx317","article-title":"The cerebellar cognitive affective\/Schmahmann syndrome scale","volume":"141","author":"Hoche","year":"2018","journal-title":"Brain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2015.11.021","article-title":"Depression and clinical progression in spinocerebellar ataxias","volume":"22","author":"Lo","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.parkreldis.2017.10.007","article-title":"Dystonia and ataxia progression in spinocerebellar ataxias","volume":"45","author":"Kuo","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5334\/tohm.346","article-title":"Postural tremor and ataxia progression in spinocerebellar ataxias","volume":"7","author":"Gan","year":"2017","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12311-019-01016-6","article-title":"Tremor in the degenerative cerebellum: towards the understanding of brain circuitry for tremor","volume":"18","author":"Lai","year":"2019","journal-title":"Cerebellum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5334\/tohm.244","article-title":"Vascular risk factors and clinical progression in spinocerebellar ataxias","volume":"5","author":"Lo","year":"2015","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awu174","article-title":"Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes","volume":"137","author":"du Montcel","year":"2014","journal-title":"Brain."},{"key":"B22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/mds.27258","article-title":"C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias","volume":"33","author":"Figueroa","year":"2018","journal-title":"Mov Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2020.02.004","article-title":"The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3","volume":"72","author":"Gan","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias : clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ana.410430215","article-title":"Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1","volume":"43","author":"Mascalchi","year":"1998","journal-title":"Ann Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12311-008-0025-0","article-title":"Magnetic resonance imaging in spinocerebellar ataxias","volume":"7","author":"D\u00f6hlinger","year":"2008","journal-title":"Cerebellum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1523\/JNEUROSCI.5612-09.2010","article-title":"Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1","volume":"30","author":"\u00d6z","year":"2010","journal-title":"J Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.nbd.2014.11.011","article-title":"Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology","volume":"74","author":"\u00d6z","year":"2015","journal-title":"Neurobiol Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/brain\/aws369","article-title":"Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6","volume":"136","author":"Reetz","year":"2013","journal-title":"Brain."},{"key":"B30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.nicl.2018.06.011","article-title":"Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes","volume":"19","author":"Adanyeguh","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00415-013-7186-6","article-title":"White matter damage is related to ataxia severity in SCA3","volume":"261","author":"Kang","year":"2014","journal-title":"J Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fneur.2020.00411","article-title":"Assessment of cerebral and cerebellar white matter microstructure in spinocerebellar ataxias 1, 2, 3, and 6 using diffusion MRI","volume":"11","author":"Park","year":"2020","journal-title":"Front Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fneur.2017.00714","article-title":"Microstructural alterations in asymptomatic and symptomatic patients with spinocerebellar ataxia type 3: a tract-based spatial statistics study","volume":"8","author":"Wu","year":"2017","journal-title":"Front Neurol."},{"key":"B34","unstructured":""},{"key":"B35","unstructured":"State of California-Department of Justice-Office of the Attorney General"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00247-018-4206-9","article-title":"A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy","volume":"48","author":"Mousa","year":"2018","journal-title":"Pediatr Radiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ana.24789","article-title":"RNAi prevents and reverses phenotypes induced by mutant human ataxin-1","volume":"80","author":"Keiser","year":"2016","journal-title":"Ann Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e123193","DOI":"10.1172\/jci.insight.123193","article-title":"Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles","volume":"3","author":"Friedrich","year":"2018","journal-title":"JCI insight."},{"key":"B40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"eaap8677","DOI":"10.1126\/scitranslmed.aap8677","article-title":"Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7","volume":"10","author":"Niu","year":"2018","journal-title":"Sci Transl Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2018.05.002","article-title":"Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of ataxia in a SCA1 mouse model","volume":"116","author":"P\u00e9rez Ortiz","year":"2018","journal-title":"Neurobiol Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2017.0209","article-title":"CRISPR\/Cas9-targeted deletion of polyglutamine in spinocerebellar ataxia type 3-derived induced pluripotent stem cells","volume":"27","author":"Ouyang","year":"2018","journal-title":"Stem Cells Dev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096368916X694373","article-title":"Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I\/IIa clinical study","volume":"26","author":"Tsai","year":"2017","journal-title":"Cell Transplant."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10072-016-2594-x","article-title":"High relative frequency of SCA1 in Poland reflecting a potential founder effect","volume":"37","author":"Krysa","year":"2016","journal-title":"Neurol Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neulet.2009.03.015","article-title":"Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin","volume":"454","author":"Vel\u00e1zquez","year":"2009","journal-title":"Neurosci Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/archneur.58.7.1105","article-title":"Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6","volume":"58","author":"Soong","year":"2001","journal-title":"Arch Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0404.2005.00349.x","article-title":"The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population","volume":"111","author":"Juvonen","year":"2005","journal-title":"Acta Neurol Scand."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:26:45Z","timestamp":1598416005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":49,"alternative-id":["10.3389\/fneur.2020.00902"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00902","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"article-number":"902"}}